Hims & Hers Health EBIT

As of the most recent data (June 2026), HIMS shows a EBIT of $-79M. That compares with $120M in the prior-year period — down 164.8% year over year. That is below the Consumer Staples sector average of $15B. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, HIMS's EBIT is now $-79M (was $120M) — a 164.8% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Hims & Hers Health is outperforming or lagging.

The Consumer Staples sector average EBIT is about $15B. Hims & Hers Health is at $-79M, which is lower that average. That is roughly 100.5% below the sector mean. Use the comparison chart on this page to see how HIMS stacks up against individual peers as well.

Tracking HIMS's ebit over time shows whether Hims & Hers Health is scaling, shrinking, or reshaping that part of the business. The current reading is $-79M That compares with $120M in the prior-year period — down 164.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this ebit page, Stockcircle has Hims & Hers Health's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $-79M) with ownership activity and broader fundamentals.